Concepedia

Valerijus Ostapenko

VO

19

Publications

952

Citations

14

H-Index

2001

Active since

Affiliations

National Cancer Institute(Current)

Vilnius University

Breast Center

University Hospital of Basel

Klinik Hirslanden

Valerijus Ostapenko is an author at National Cancer Institute specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

2001–2023

19

Publications

19

Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer

Stephen Chan, M. E. Scheulen, S. Johnston et al. · Journal of Clinical Oncology · 2005 · 468 citations · Full text

Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays

Aida Laurinavičienė, Darius Dasevičius, Valerijus Ostapenko et al. · Diagnostic Pathology · 2011 · 65 citations · Full text

Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data

Arvydas Laurinavičius, Aida Laurinavičienė, Valerijus Ostapenko et al. · Diagnostic Pathology · 2012 · 64 citations · Full text

Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)

William P. Weber, Zoltán Mátrai, Stefanie Hayoz et al. · The Breast · 2021 · 59 citations · Full text

A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer

Patricia Pautier, Ignace Vergote, Florence Joly et al. · International Journal of Gynecological Cancer · 2016 · 38 citations · Full text

Rows per page

1–5 of 19